tiprankstipranks
Advertisement
Advertisement

LYRA Stock Latest News

Lyra Therapeutics Streamlines Operations with Major Lease Terminations
Company AnnouncementsLyra Therapeutics Streamlines Operations with Major Lease Terminations
6d ago
8K
LYRA
Lyra Therapeutics Withdraws Nasdaq Appeal, Faces Imminent Delisting
PremiumCompany Announcements
Lyra Therapeutics Withdraws Nasdaq Appeal, Faces Imminent Delisting
1M ago
8K
LYRA
LYRA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LYRA Earnings this Week: How Will it Perform?
1M ago
LYRA
Lyra Therapeutics Faces Nasdaq Delisting After Becoming Shell
PremiumCompany Announcements
Lyra Therapeutics Faces Nasdaq Delisting After Becoming Shell
2M ago
8K
LYRA
Lyra Therapeutics common stock to be delisted by Nasdaq
PremiumThe Fly
Lyra Therapeutics common stock to be delisted by Nasdaq
2M ago
LYRA
One new option listing and option delistings on January 20th
PremiumThe FlyOne new option listing and option delistings on January 20th
3M ago
CVM
TEF
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
3M ago
AMD
ANF
Why Is Lyra Therapeutics Stock (LYRA) Down Today?
Premium
Market News
Why Is Lyra Therapeutics Stock (LYRA) Down Today?
3M ago
LYRA
Lyra Therapeutics Halts LYR-210, Cuts Workforce, Explores Options
PremiumCompany Announcements
Lyra Therapeutics Halts LYR-210, Cuts Workforce, Explores Options
3M ago
8K
LYRA
Lyra Therapeutics suspends further development of LYR-210
PremiumThe Fly
Lyra Therapeutics suspends further development of LYR-210
3M ago
LYRA
Cautious Hold Rating for Lyra Therapeutics Amid Strategic Focus and Financial Challenges
PremiumRatings
Cautious Hold Rating for Lyra Therapeutics Amid Strategic Focus and Financial Challenges
5M ago
LYRA
Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks
PremiumCompany Announcements
Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks
5M ago
LYRA
Lyra Therapeutics reports Q3 EPS ($3.38), consensus ($4.07)
PremiumThe FlyLyra Therapeutics reports Q3 EPS ($3.38), consensus ($4.07)
5M ago
LYRA
LYRA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LYRA Upcoming Earnings Report: What to Expect?
5M ago
LYRA
Lyra Therapeutics announces clinical plan for LYR-210
Premium
The Fly
Lyra Therapeutics announces clinical plan for LYR-210
6M ago
LYRA
Lyra Therapeutics Posts Corporate Presentation on LYR-210
PremiumCompany Announcements
Lyra Therapeutics Posts Corporate Presentation on LYR-210
7M ago
8K
LYRA
Lyra Therapeutics Receives Nasdaq Deficiency Letter
PremiumCompany Announcements
Lyra Therapeutics Receives Nasdaq Deficiency Letter
8M ago
8K
LYRA
Cautious Hold Rating on Lyra Therapeutics Amid Uncertainty in LYR-210’s Development and Approval Prospects
PremiumRatings
Cautious Hold Rating on Lyra Therapeutics Amid Uncertainty in LYR-210’s Development and Approval Prospects
8M ago
LYRA
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift
PremiumCompany Announcements
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift
8M ago
LYRA
Lyra Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsLyra Therapeutics Reports Q2 2025 Financial Results
8M ago
LYRA
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78)
Premium
The Fly
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78)
8M ago
LYRA
Is LYRA a Buy, Before Earnings?
Premium
Pre-Earnings
Is LYRA a Buy, Before Earnings?
8M ago
LYRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >